Essex Investment Management Co. LLC grew its stake in shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) by 55.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,238,664 shares of the medical equipment provider’s stock after purchasing an additional 440,601 shares during the period. Essex Investment Management Co. LLC’s holdings in Corindus Vascular Robotics were worth $1,251,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Goldman Sachs Group Inc. raised its position in shares of Corindus Vascular Robotics by 147.8% during the 2nd quarter. Goldman Sachs Group Inc. now owns 58,824 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 35,086 shares during the last quarter. Rhumbline Advisers raised its position in shares of Corindus Vascular Robotics by 67.6% during the 2nd quarter. Rhumbline Advisers now owns 80,868 shares of the medical equipment provider’s stock worth $150,000 after purchasing an additional 32,608 shares during the last quarter. New York State Common Retirement Fund raised its position in shares of Corindus Vascular Robotics by 334.6% during the 2nd quarter. New York State Common Retirement Fund now owns 89,100 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 68,599 shares during the last quarter. California State Teachers Retirement System raised its position in shares of Corindus Vascular Robotics by 34.4% during the 2nd quarter. California State Teachers Retirement System now owns 148,558 shares of the medical equipment provider’s stock worth $276,000 after purchasing an additional 38,000 shares during the last quarter. Finally, Teachers Advisors LLC raised its position in shares of Corindus Vascular Robotics by 184.7% during the 2nd quarter. Teachers Advisors LLC now owns 167,633 shares of the medical equipment provider’s stock worth $312,000 after purchasing an additional 108,745 shares during the last quarter.

CVRS has been the subject of several research reports. Zacks Investment Research upgraded Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a research report on Monday, November 13th. BidaskClub downgraded Corindus Vascular Robotics from a “sell” rating to a “strong sell” rating in a research report on Wednesday, October 11th. Three research analysts have rated the stock with a sell rating and two have given a buy rating to the company’s stock. Corindus Vascular Robotics has an average rating of “Hold” and an average target price of $2.33.

Shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) opened at $1.03 on Thursday. The company has a market cap of $170.63, a P/E ratio of -4.29 and a beta of 19.34. Corindus Vascular Robotics Inc has a 12 month low of $0.49 and a 12 month high of $2.25.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last released its earnings results on Tuesday, November 7th. The medical equipment provider reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.05) by $0.01. The firm had revenue of $2.43 million during the quarter, compared to analysts’ expectations of $3.60 million. Corindus Vascular Robotics had a negative net margin of 323.84% and a negative return on equity of 110.93%.

WARNING: “Essex Investment Management Co. LLC Boosts Stake in Corindus Vascular Robotics Inc (CVRS)” was posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.dailypolitical.com/2018/02/08/essex-investment-management-co-llc-boosts-stake-in-corindus-vascular-robotics-inc-cvrs.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

Want to see what other hedge funds are holding CVRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS).

Institutional Ownership by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.